The antibody is used to bind the FGF receptor 4 (FGFR4) and the medical use thereof, in particular for the diagnosis prevention or treatment of diseases associated with FGFR expression, overexpression or hyperactivity.
Figure 1 Three examples of anti-FGFR4 antibodies bind specifically to FGFR4.
The binding of antibodies XPA.48.056, XPA.48.117, and XPA.48.148 was evaluated by measuring binding to CHO-hFGFR4 cells (Panel A); HepG2 (Panel B); and HuH7 cells (Panel C) by FACS.
Figure 2 Three examples of anti-FGFR4 antibodies are capable of neutralizing FGF-19 induced phosphorylation of intracellular proteins.
Each of the three example antibodies were able to neutralize pERK (FIG. 4, Panel A) and pGSK-3P (FIG. 4, Panel B) in the presence of a sub-maximal concentration of rfiFGF-19 as measured using electrochemiluminescence.
Figure 3 Three examples of anti-FGFR4 antibodies are capable of mediating antibody-dependent cellular cytotoxicity in HepG2 cells (Panel A), HuH-7 cells (Panel B) and HCT116-FGFR4 cells (Panel C).
Percent specific cytotoxicity was calculated using 1 or 10 mg/ml antibody.
Figure 4 Three examples of anti-FGFR4 antibodies are capable of binding to mouse FGFR4 in addition to human FGFR4.
Panel A shows dose-dependent binding of XPA.48.056, XPA.48.117, and XPA.48.148 to endogenous AML12 mouse hepatocytes as measured by flow cytometry. Panel B shows FACS binding of 50 nM XPA.48.056, XPA.48.117, and XPA.48.148 to HEK293E cells transiently transfected with mouse FGFR4 cDNA. Data was normalized to the degree of signal measured for untransfected cells.
Figure 5 Three examples of anti-FGFR4 antibodies are capable of inhibiting tumor growth in the HuH-7 xenograft model.
Antibodies were administered at 30 mg/kg/week for a total of 4 weeks (15 mice per group).
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-3383z | Mouse Anti-FGFR4 Recombinant Antibody (clone 31F7) | WB, IP, IF, IHC, ELISA | Mouse IgG1, κ |
MOB-0739CT | Recombinant Mouse anti-Human FGFR4 Monoclonal antibody (NN0390-7I44) | WB | |
HPAB-2922LY | Mouse Anti-FGFR4 Recombinant Antibody (HPAB-2922LY) | ELISA, FC | Mouse IgG |
HPAB-0442-FY | Human Anti-FGFR4 Recombinant Antibody (HPAB-0442-FY) | Inhib | Human IgG |
VS1-YJ59 | Mouse Anti-FGFR4 Recombinant Antibody (clone 19H3) | WB, IP | Mouse IgG1 |
There are currently no Customer reviews or questions for HPAB-0058-LS. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.